Facts about DES and breast cancer

Centers for Disease Control and Prevention (U.S.)

DES – a synthetic estrogen that was prescribed to pregnant women during 1938—1971 to prevent miscarriages or premature delivery – has been linked to several health risks. Included among these, is an increased risk of breast cancer among women who were prescribed DES while pregnant and DES Daughters – women who were exposed to DES in the womb. Research available through CDC’s DES Update currently confirms the following facts pertaining to the affect of DES exposure on a woman’s risk for breast cancer. Publication date from document properties. DES&BreastCancerFS.pdf

Pamphlet (or booklet)

Fact Sheet

Stephen B. Thacker CDC Library collection